BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MDS Diagnostic Services (MDZ) Announces New Fee Arrangement In Ontario


4/7/2006 10:26:43 AM

TORONTO, April 7 /PRNewswire-FirstCall/ - MDS Diagnostic Services, a leading provider of laboratory testing and management services in Canada, today announced that the Ontario Association of Medical Laboratories (OAML) has reached a new three- year funding agreement with the Ontario Ministry of Health and Long Term Care (MOH) for the provision of community laboratory services, which are used by physicians and other health care providers to help in the diagnosis, treatment, monitoring and prevention of disease in patients.

The new agreement includes a 2% base increase in the provincial funding cap for each of the years ending in March 31, 2006, March 31, 2007, and March 31, 2008, for community laboratory services performed under the Ontario Health Insurance Plan (OHIP). MDS, which provides approximately 31.6% of community laboratory services in Ontario, would receive its proportional share of these increases.

The agreement also provides for adjustment funding should certain industry volume thresholds be reached as a result of accommodating the needs of long-term care patients and new physicians among other criteria. Under this arrangement, funding adjustments could be made to a maximum of 0.8%, 2.9% and 4.9% over the March 31, 2005 provincial funding cap, for each of the years ending March 31, 2006, March 31, 2007, and March 31, 2008, respectively. If earned, these funding adjustments would be paid annually to OAML members according to their respective proportional shares of the provincial funding cap, as part of the MOH year-end reconciliation process.

The agreement is retroactive to April 1, 2005, which is when the previous agreement expired. Accordingly, in the second quarter ending April 30, 2006 MDS will recognize approximately $3.7 million of previously unrecognized revenue for the period from April 1, 2005 to April 30, 2006.

MDS Diagnostic Services, a business unit of MDS Inc. , is a leading provider of laboratory testing and management services. MDS Inc. is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 8,800 highly skilled people in 28 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.

MDS Inc.

CONTACT: Sharon Mathers, Vice-President, Investor Relations, (416)675-6777 ext. 2695, smathers@mdsinc.com


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->